Equity incl. NCI
Balance – as of period end · $M
FY2021
1,462$M
All values (5)
| Period | Value ($M) | Status |
|---|---|---|
| FY2025 | 2,216 | reported |
| FY2024 | 1,896 | reported |
| FY2023 | 1,771 | reported |
| FY2022 | 1,676 | reported |
| FY2021 | 1,462 | reported |
| FY2016 – FY2020 | – | missing (5 periods): No verified SEC value extracted, although the company reports this metric in other periods. |
Show reported periods only · CSV with all sources · Technical ID: equity_total
More metrics for Celestica
Income statement
Balance sheet
Debt and interest
Revenue by segment/product/region
Operating income by segment
Sources & calculation
- Value
- $1.5B
- Period
- FY2021, ended Dec 31, 2021 · as of Dec 31, 2021 (balance as of date, not a sum)
- Source
- 10-K, filed Mar 3, 2025 · 0001030894-25-000014
- Location
- us-gaap:StockholdersEquity
- Confidence
- 1. – directly from an XBRL fact in the filing (or calculated exactly from it)
Versions
| v1 | $1.5B | Mar 3, 2025 | 10-K 0001030894-25-000014 | reported · confidence 1. · current |